Lung cancer screening for family and friends of lung cancer patients
Lung Cancer Screening in Family Members and Peers of Lung Cancer Patients: a Prospective Cohort Study
This study is testing if yearly low-dose CT scans can help find lung cancer earlier in family and friends of lung cancer patients who may be at higher risk.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | McGill University Health Centre/Research Institute of the McGill University Health Centre Academic / other |
| Locations | 1 site (Montréal, Quebec) |
| Trial ID | NCT05645731 on ClinicalTrials.gov |
What this trial studies
This study focuses on screening family members and close contacts of lung cancer patients for lung cancer using yearly low-dose CT scans. It aims to determine if these referred individuals have a higher risk of developing lung cancer compared to those referred by their family doctors. The approach leverages the understanding that shared genetics, environment, and lifestyle factors contribute to increased lung cancer risk in these populations. By engaging lung cancer patients to refer their loved ones, the study seeks to empower patients and improve early detection rates.
Who should consider this trial
Good fit: Ideal candidates include family members and close contacts of current or former lung cancer patients who are over 18 years old.
Not a fit: Patients with a personal history of lung cancer will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to earlier lung cancer diagnoses and improved survival rates for at-risk individuals.
How similar studies have performed: Other studies have shown success in lung cancer screening approaches, particularly among high-risk populations, suggesting this method could be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Lung cancer patients: Inclusion Criteria: * \> 18 years old * Current or former lung cancer patient Exclusion Criteria: none Referred participants Inclusion criteria: \>18 years old Exclusion criteria: Personal history of lung cancer.
Where this trial is running
Montréal, Quebec
- Muhc — Montréal, Quebec, Canada (Recruiting)
Study contacts
- Principal investigator: Nicole Ezer, MD — Research Institute of the McGill University Health Center
- Study coordinator: Nicole Ezer, MD
- Email: nicole.ezer@mcgill.ca
- Phone: (514)-934-1934
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.